Project Details
| Status | Active |
|---|---|
| Effective start/end date | 10/29/18 → 10/29/24 |
Funding
- PRA Health Sciences ((OE) Prot #BST002 // (OE) Prot #BST002)
- BioSight Ltd. ((OE) Prot #BST002 // (OE) Prot #BST002)
Prot #BST002: A Phase 2b, Open-Label, Single Arm, Multi-Center Study to Assess the Efficacy and Safety of BST-236 as a Single Agent in Adults with Newly-Diagnosed Acute Myeloid Leukemia, Not Eligible for Standard Induction Therapy
- Frankfurt, Olga (PD/PI)
Project: Research project